X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59) 59
humans (52) 52
male (48) 48
female (43) 43
middle aged (36) 36
aged (31) 31
adult (25) 25
analysis (21) 21
risk factors (18) 18
cardiac & cardiovascular systems (17) 17
peripheral vascular disease (17) 17
animals (14) 14
heart failure (13) 13
inflammation (13) 13
abridged index medicus (12) 12
aged, 80 and over (11) 11
hematology (11) 11
time factors (11) 11
cardiovascular (10) 10
heart attacks (10) 10
treatment outcome (10) 10
article (9) 9
care and treatment (9) 9
genetic aspects (9) 9
interleukin-1 (9) 9
myocardial-infarction (9) 9
c-reactive protein (8) 8
cardiology (8) 8
cardiovascular diseases (8) 8
double-blind method (8) 8
follow-up studies (8) 8
rats (8) 8
research (8) 8
case-control studies (7) 7
heart (7) 7
myocardial infarction (7) 7
oxidative stress (7) 7
thrombosis (7) 7
biomarkers - blood (6) 6
chi-square distribution (6) 6
clinical trials (6) 6
cytokines (6) 6
disease (6) 6
expression (6) 6
genetic predisposition to disease (6) 6
heart attack (6) 6
homocysteine (6) 6
mice (6) 6
odds ratio (6) 6
physiology (6) 6
pilot projects (6) 6
polymorphism, single nucleotide (6) 6
atherosclerosis (5) 5
biochemistry & molecular biology (5) 5
c-reactive protein - metabolism (5) 5
cardiac patients (5) 5
cardiology and cardiovascular medicine (5) 5
disease models, animal (5) 5
fibrinolysis (5) 5
gene frequency (5) 5
genes (5) 5
genotype (5) 5
heart failure - physiopathology (5) 5
heart-failure (5) 5
heme oxygenase-1 - metabolism (5) 5
hypertension (5) 5
interleukins (5) 5
italy - epidemiology (5) 5
logistic models (5) 5
metabolism (5) 5
multivariate analysis (5) 5
prospective studies (5) 5
proteins (5) 5
rats, wistar (5) 5
risk-factor (5) 5
activated protein-kinase (4) 4
adiponectin (4) 4
aortic aneurysm, abdominal - genetics (4) 4
association (4) 4
blood (4) 4
cardiovascular disease (4) 4
cell biology (4) 4
clinical medicine (4) 4
clopidogrel (4) 4
coronary-artery-disease (4) 4
diabetes (4) 4
diagnosis (4) 4
dose-response relationship, drug (4) 4
gene expression (4) 4
genetic research (4) 4
heart failure - diagnosis (4) 4
heart-disease (4) 4
heme oxygenase-1 (4) 4
infection (4) 4
infectious diseases (4) 4
inhibition (4) 4
interleukin 1 receptor antagonist protein - administration & dosage (4) 4
interleukin 1 receptor antagonist protein - therapeutic use (4) 4
interleukin-1 - antagonists & inhibitors (4) 4
italy (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
by Ray, Kausik K and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Diaz, Rafael and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Loizeau, Virginie and Lopes, Renato D and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and Zeiher, Andreas M and Schwartz, Gregory G and Steg, Philippe Gabriel and Schwartz, Gregory G and Steg, Ph. Gabriel and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Goodman, Shaun G and Harrington, Robert A and Jukema, J. Wouter and Szarek, Michael and White, Harvey D and Zeiher, Andreas M and Tricoci, Pierluigi and Roe, Matthew T and Mahaffey, Kenneth W and Edelberg, Jay M and Hanotin, Corinne and Lecorps, Guillaume and Moryusef, Angèle and Pordy, Robert and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Lopes, Renato D and Gotcheva, Nina N and Prieto, Juan-Carlos and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Takeshi and Kim, Hyo Soo and Kim, Sang-Hyun and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Budaj, Andrzej and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Ristic, Arsen D and Chua, Terrance and Murin, Jan and Fras, Zlatko and Dalby, Anthony J and Tuñón, José and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Ray, Kausik K and Moriarty, Patrick M and Vogel, Robert and ... and ODYSSEY OUTCOMES Committees and Investigators and ODYSSEY OUTCOMES Comm Investigato and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article